tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Werewolf Therapeutics Announces Major Workforce and Leadership Restructuring
PremiumCompany AnnouncementsWerewolf Therapeutics Announces Major Workforce and Leadership Restructuring
1M ago
Werewolf Therapeutics announces 64% workforce reduction
Premium
The Fly
Werewolf Therapeutics announces 64% workforce reduction
1M ago
Werewolf Therapeutics Receives Nasdaq Minimum Bid Price Notice
Premium
Company Announcements
Werewolf Therapeutics Receives Nasdaq Minimum Bid Price Notice
1M ago
Werewolf Therapeutics price target lowered to $4 from $10 at H.C. Wainwright
PremiumThe FlyWerewolf Therapeutics price target lowered to $4 from $10 at H.C. Wainwright
3M ago
Clinical Momentum and Platform Validation Drive Undervalued Upside at Werewolf Therapeutics
Premium
Ratings
Clinical Momentum and Platform Validation Drive Undervalued Upside at Werewolf Therapeutics
3M ago
Werewolf Therapeutics Updates Pipeline and Outlines 2026 Priorities
Premium
Company Announcements
Werewolf Therapeutics Updates Pipeline and Outlines 2026 Priorities
3M ago
Werewolf Therapeutics Reports Q3 2025 Financial Results
PremiumCompany AnnouncementsWerewolf Therapeutics Reports Q3 2025 Financial Results
5M ago
Werewolf Therapeutics reports Q3 EPS (36c), consensus (38c)
Premium
The Fly
Werewolf Therapeutics reports Q3 EPS (36c), consensus (38c)
5M ago
Werewolf Therapeutics’ WTX-330 Study: A Potential Game-Changer in Oncology
Premium
Company Announcements
Werewolf Therapeutics’ WTX-330 Study: A Potential Game-Changer in Oncology
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100